Direxion Daily S&P Biotech Bull 3X Shares
看多
已更新

LABU / LABD Ratio Anchored VWAP over /under LABU LONG

149
On the weekly chart a LABU / LABD ratio is plotted with anchored VWAP bands and a volume

profile overlaid. I wanted to analyze this to affirm the highest of prospects for the

Biotechnology sector for 2024. LABU is triple leveraged Up while LABD is the inverse Down.

A good unleveraged biotech ETF is XBI. The chart shows LABU in a VWAP band and breakout

through the hohg volume area and then over it beginning early November. Unusually high

relative volume and volatility ramped up about the same time.

I readily conclude that LABU is the buy right now with the ratio rising. It is a low beat ETF

with good range due to the leveraging and high forecasts for 2024. I will make buys on

LABU at regular intervals on a 60-120 minute time frame looking for the weekly lows.

I will set an alert for a falling ratio on the 3H to daily chart to assess should the supertrend

fade. I believe that this will be a safe low risk swing long trade.
交易進行
Trade plan zoomed in linked here:

快照
交易進行
This is a falling wedge breakout and fade with recovery upside

快照
註釋
It could end up making another falling wedge which remains to play out or not.
交易進行
LABu up today and the ratio rises as expected.
交易進行
Ratio is sideways at this time

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。